Hepatitis C virus infection affects over 58 million individuals and is responsible for 290,000
annual deaths. The infection spread in the past via blood transfusion and iatrogenic …

Abstract Introduction Hepatitis C virus (HCV) is a major public health threat. Although the
recent availability of highly effective directly acting antivirals created optimism towards HCV …

Abstract Background Direct-acting antivirals (DAAa) cure hepatitis C virus (HCV) infections
in 95% of infected patients. Modeling studies predict that universal HCV treatment will lead …

Background Broad direct-acting antiviral (DAA) access may reduce hepatitis C virus (HCV)
incidence through a" treatment as prevention"(TasP) effect. We assessed changes in …

Objectives and design: Hepatitis C virus (HCV) has been recognized as an emerging
sexually transmitted infection (STI) among HIV-positive MSM. However, HIV-negative MSM …

Summary Background In the Netherlands, access to direct-acting antivirals (DAAs) against
hepatitis C virus (HCV) has been unrestricted for chronic infection since 2015. We evaluated …

Background Micro-elimination of the hepatitis C virus (HCV) includes treatment in
populations at risk of ongoing HCV transmission, such as men who have sex with men …

Background & Aims Hepatitis C virus (HCV) incidence among HIV-positive men who have
sex with men (MSM) has increased since 2000, although there are regional differences. We …

Abstract Background The Netherlands has provided unrestricted access to direct-acting
antivirals (DAAs) since November 2015. We analyzed the nationwide hepatitis C virus …

Current Opinion in Infectious Diseases Log in or Register Subscribe to journalSubscribe Get
new issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation …